SCHEMBL7146736

SCHEMBL7146736

COC(=O)c1cc(NC(=O)OC(C)(C)C)c(N)cc1I

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 3/20 0.44
ATR Q13535 1/20 0.42
KDM4E B2RXH2 4/20 0.38
AAK1 Q2M2I8 5/20 0.38
GAA P10253 4/20 0.37
MAPT P10636 3/20 0.37
MAPK1 P28482 1/20 0.37
ALDH1A1 P00352 3/20 0.37
HSD17B10 Q99714 3/20 0.37
HPGD P15428 2/20 0.37
GLA P06280 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
ATM Q13315 1/20 0.37
NQO2 P16083 1/20 0.36
ABL1 P00519 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
CISD2 Q8N5K1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7139788 0.80 ATR (0.39) ATRKDM4EMAPTMAPK1ALDH1A1
SCHEMBL27214479 0.78 ATR (0.42) CFTRATRKDM4EAAK1GAA
SCHEMBL31554221 0.77 AAK1 (0.41) CFTRATRKDM4EAAK1GAA
SCHEMBL24162849 0.77 ATR (0.43) CFTRATRKDM4EGAAMAPT
SCHEMBL7139941 0.75 ATR (0.38) CFTRATRKDM4EGAAMAPT
SCHEMBL4212736 0.75 CA12 (0.41) AAK1RXFP1CISD2
SCHEMBL17822878 0.75 ATR (0.47) ATRKDM4EGAAALDH1A1RXFP1
SCHEMBL6163196 0.75 GAA (0.49) CFTRATRKDM4EGAAMAPT
SCHEMBL4516629 0.75 MAPT (0.55) KDM4EAAK1GAAMAPTMAPK1
SCHEMBL6438753 0.74 AAK1 (0.36) AAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed